ECO Animal Health Group (LON:EAH) Receives Buy Rating from Shore Capital

Shore Capital reissued their buy rating on shares of ECO Animal Health Group (LON:EAH) in a research note released on Friday morning, Marketbeat Ratings reports.

ECO Animal Health Group Stock Performance

EAH stock opened at GBX 71.25 ($0.90) on Friday. The stock’s 50 day simple moving average is GBX 74.68 and its 200 day simple moving average is GBX 101.87. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.31. ECO Animal Health Group has a 12-month low of GBX 60 ($0.76) and a 12-month high of GBX 135 ($1.71). The stock has a market capitalization of £48.26 million, a PE ratio of 3,740.00 and a beta of -0.05.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.